Research and analysis

Evaluation of LFD performance within the National Testing Programme

These reports summarise the performance of different lateral flow devices (LFDs) used across various test settings and services within the National Testing Programme.

Documents

Evaluation of lateral flow device performance within the National Testing Programme

Evaluation of Lateral Flow Device performance to diagnose SARS- CoV2 (evidence from Performance data February 2021 to March 2022

Key points summary: asymptomatic testing for SARS-CoV-2 using antigen-detecting lateral flow devices (evidence from performance data October 2020 to May 2021)

Asymptomatic testing for SARS-CoV-2 using antigen-detecting lateral flow devices

Details

These reports summarise the performance and efficacy of the LFDs used for SARS-CoV-2 testing in the UK between October 2020 to March 2022.

They cover a number of areas including:

  • laboratory assessment of LFDs and evaluation of the testing procedures that are implemented before their deployment
  • post-deployment evaluations of LFD test performance due to specific changes that may affect implementation
  • evaluation of innovations and improvements

They provide insights into ongoing efforts to evaluate and improve the performance of LFD tests deployed within the national testing program.

Updates to this page

Published 21 March 2024

Sign up for emails or print this page